184 related articles for article (PubMed ID: 16004825)
1. [Research advance on molecular and cellular biology of small cell lung cancer].
Ji FY; Qian GS; Huang GJ
Ai Zheng; 2005 Jul; 24(7):903-8. PubMed ID: 16004825
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cellular biology of small cell lung cancer.
Sattler M; Salgia R
Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
4. [Biology of small-cell bronchogenic carcinoma: recent advances].
Levy R; Andrieu JM; Even P
Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and molecular aspects of lung cancer.
Panani AD; Roussos C
Cancer Lett; 2006 Jul; 239(1):1-9. PubMed ID: 16112428
[TBL] [Abstract][Full Text] [Related]
6. Molecular implications of recurrent cytogenetic alterations in human small cell lung cancer.
Testa JR; Graziano SL
Cancer Detect Prev; 1993; 17(2):267-77. PubMed ID: 8402711
[TBL] [Abstract][Full Text] [Related]
7. Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?
Fischer B; Marinov M; Arcaro A
Cancer Treat Rev; 2007 Jun; 33(4):391-406. PubMed ID: 17368733
[TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p.
Graziano SL; Cowan BY; Carney DN; Bryke CR; Mitter NS; Johnson BE; Mark GE; Planas AT; Catino JJ; Comis RL
Cancer Res; 1987 Apr; 47(8):2148-55. PubMed ID: 3030544
[TBL] [Abstract][Full Text] [Related]
9. [Recent progress in the biology of small cell bronchial carcinoma].
Thomas F; Arriagada R; Le Chevalier T; Poupon MF
Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tumors of the lung. Pathology and molecular biology.
Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
[TBL] [Abstract][Full Text] [Related]
11. The molecular and cellular basis of human lung cancer.
Gazdar AF
Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
[TBL] [Abstract][Full Text] [Related]
12. [Recent advances in pathology and biology of small cell lung cancer].
Shimosato Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2513-21. PubMed ID: 2549878
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of lung tumor suppressor activity at 3p21.3.
ter Elst A; Hiemstra BE; van der Vlies P; Kamminga W; van der Veen AY; Davelaar I; Terpstra P; te Meerman GJ; Gerbens F; Kok K; Buys CH
Genes Chromosomes Cancer; 2006 Dec; 45(12):1077-93. PubMed ID: 16958100
[TBL] [Abstract][Full Text] [Related]
14. Peptide hormones and lung cancer.
Moody TW
Panminerva Med; 2006 Mar; 48(1):19-26. PubMed ID: 16633328
[TBL] [Abstract][Full Text] [Related]
15. The role of new targeted therapies in small-cell lung cancer.
Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
[TBL] [Abstract][Full Text] [Related]
16. Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.
Poulsen TT; Pedersen N; Perin MS; Hansen CK; Poulsen HS
Lung Cancer; 2005 Dec; 50(3):329-37. PubMed ID: 16115696
[TBL] [Abstract][Full Text] [Related]
17. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype relationships in a mouse model for human small-cell lung cancer.
Calbó J; Meuwissen R; van Montfort E; van Tellingen O; Berns A
Cold Spring Harb Symp Quant Biol; 2005; 70():225-32. PubMed ID: 16869758
[TBL] [Abstract][Full Text] [Related]
19. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2/DR5 expression in the absence of caspase-8.
Belyanskaya LL; Ziogas A; Hopkins-Donaldson S; Kurtz S; Simon HU; Stahel R; Zangemeister-Wittke U
Lung Cancer; 2008 Jun; 60(3):355-65. PubMed ID: 18093694
[TBL] [Abstract][Full Text] [Related]
20. Biology and novel therapeutics for neuroendocrine tumors of the lung.
Jafri N; Salgia R
J Biol Regul Homeost Agents; 2004; 18(3-4):275-90. PubMed ID: 15786694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
